Johnson & Johnson Sept. 30 notified the Health Resources and Services Administration that it is ceasing implementation of its ...

The EU's increasing reliance on pharmaceutical production from non-EU countries, particularly India and China, has raised ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

If unorthodoxy and discipline could be blended and bottled, Bob Duggan would have another multibillion-dollar product. For now, his fortunes are focused on an experimental cancer drug that wowed ...

Analyst Kostas Biliouris of BMO Capital maintained a Hold rating on BridgeBio Pharma (BBIO – Research Report), retaining the price target ...

Rising prescription costs disproportionately affect African Americans, causing life-threatening decisions. Pharmacy benefit ...

Among biopharma firms, size didn’t always correlate with the highest wages, a recently debuted analysis of ‘best’ pharma ...

Teva Pharmaceutical Indus TEVA +2.72% Get Free Report has outperformed the market over the past 5 years by 6.63% on an ...

Nearly 30% of containerized pharmaceutical imports in the U.S. enter through the Port of Charleston, SC. If port strikes ...

"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...

The magnesium hydroxide market sales are poised for significant growth, with projections indicating a compound annual growth ...